ALS ONE's 5th Annual ALS ONE Research Symposium, held Oct. 6, 7, & 11, 2022, hosted by our research team: Dr’s Merit Cudkowicz, MD, MSc of MGH, Robert Brown, MD, DPhil of UMass Medical School, James Berry, MD, MPH of MGH, Sabrina Paganoni, MD, PhD of MGH, and Fernando Vieira, MD of ALS TDI. The conference had over 960 registered guests from 34 countries, including researchers, scientists, and members of the ALS community from around the world, convening virtually for 3 days of sharing critical research that is underway across the globe to help uncover therapeutic options leading to an ultimate cure for Amyotrophic Lateral Sclerosis (ALS). Recordings were made of the presentations which we are/were approved to share.
IN THIS VIDEO:
Symposium Segment: CURRENT STATE OF ALS TRIALS
Presentation Title: Update on EAP & ACT 4 ALS
Speaker: Sabrina Paganoni, MD, PhD, Co-Director of the Neurological Research Institute (NCRI) at the Massachusetts General Hospital, physician scientist at the Healey & AMG Center for ALS, and Associate Professor at Harvard Medical School.
Moderator: James Berry, MD, MPH, Associate Chief of Neuro-therapeutics and Chief of the Division of ALS and Motor Neuron Diseases at Massachusetts General Hospital (MGH) and Director of the MGH Neurological Clinical Research Institute (NCRI).
ALS ONE is a 501c3 non-profit organization focused entirely on ALS research and care. To learn more about ALS ONE and/or support our mission, visit: www.alsone.org.
